Home > Low-THC cannabis products in Europe.

European Monitoring Centre for Drugs and Drug Addiction. (2020) Low-THC cannabis products in Europe. Luxembourg: Publications Office of the European Union.

[img]
Preview
PDF (Low-THC cannabis products in Europe)
481kB

The open sale of cannabis products in Europe has raised concerns among policymakers, both with regard to the legal status of these products and their potential for harm. The products are marketed for their low THC (tetrahydrocannabinol) content, which sellers claim exempt them from control by drug laws, or as sources of CBD (cannabidiol). This publication presents an initial overview of the situation, covering the types of low-THC product available, user profiles, associated harms and regulatory responses in Europe. Low-THC products that take forms similar to illicit cannabis products, such as smoking mixtures, oils and edibles are a primary focus of this study. The report highlights the challenges facing both policymakers and those wishing to supply low-THC products regarding establishing the legal status of the products and which regulatory frameworks apply to their sale.

Item Type
Report
Publication Type
Irish-related, International, Report
Drug Type
Cannabis
Date
December 2020
Pages
19 p.
Publisher
Publications Office of the European Union
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Luxembourg
EndNote
Related (external) link

Repository Staff Only: item control page